LipoScience pulls in $45 million from public offering

01/30/2013 | Clinica (subscription required)

LipoScience has secured $45 million in a just-completed initial public offering. The Raleigh, N.C.-based in vitro diagnostics company plans to use about $38.6 million in expected net proceeds from the offering in part to fund its research and development projects, including initiatives to increase its Vantera system's test menu.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC